Your session is about to expire
← Back to Search
Brain Stimulation
rTMS + Virtual Reality Therapy for Mild Cognitive Impairment (rTMS+iVCT Trial)
N/A
Waitlist Available
Research Sponsored by Central Arkansas Veterans Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 55 and over
Score of 18 or over on the MoCA during pre-screening procedures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 weeks, 3 months
Awards & highlights
rTMS+iVCT Trial Summary
This trial is studying if brain stimulation & training can improve cognitive & mood in older adults with Mild Cognitive Impairment.
Who is the study for?
This trial is for adults over 55 with Mild Cognitive Impairment (MCI) who score at least 18 on the MoCA test. It's not suitable for those with implanted devices, under 55, seizure risks, history of certain neurological issues, or sensitivity to light and sound.Check my eligibility
What is being tested?
The study tests if brain stimulation (rTMS) combined with virtual reality cognitive training (iVCT) can improve cognition and mood in MCI patients more effectively than rTMS alone or no treatment.See study design
What are the potential side effects?
Possible side effects include discomfort from the magnetic stimulation like a mild headache or scalp sensations during rTMS. Virtual reality may cause motion sickness or nausea in some individuals.
rTMS+iVCT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 55 years old or older.
Select...
My mental function score is 18 or higher.
rTMS+iVCT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 2 weeks, 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 weeks, 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Hopkins Verbal Leaning Test Standard Score
Secondary outcome measures
Change in Functional Activities Questionnaire score
Change in NPI
rTMS+iVCT Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: rTMS+iVCTExperimental Treatment1 Intervention
This group will be randomized to receive rTMS and iVCT treatment
Group II: rTMSActive Control1 Intervention
This group will be randomized to receive rTMS treatment
Group III: Standard TreatmentActive Control1 Intervention
This arm will be followed without intervention
Find a Location
Who is running the clinical trial?
Central Arkansas Veterans Healthcare SystemLead Sponsor
23 Previous Clinical Trials
3,490 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this research effort currently taking place?
"The clinicaltrials.gov website suggests that this medical trial is not at present enrolling patients, as the study was initially posted on January 1st 2024 and its last update was on September 5th 2023. Despite this, there are still 1015 other trials which require recruitment of individuals right now."
Answered by AI
Share this study with friends
Copy Link
Messenger